gefitinib mylan
mylan pharmaceuticals limited - gefitinib - carcinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - gefitinib mylan er angivet som monoterapi til behandling af voksne patienter med lokalt fremskreden eller metastatisk ikke‑småcellet lungekræft (nsclc) med aktiverende mutationer af egfr‑tk.
juluca
viiv healthcare b.v. - dolutegravir natrium, rilpivirine hydrochlorid - hiv infektioner - antivirale midler til systemisk anvendelse - juluca er indiceret til behandling af human immundefekt virus type 1 (hiv-1) - infektion hos voksne, der er virologically-undertrykt (hiv-1 rna.
nubeqa
bayer ag - darolutamide - prostatic neoplasmer, kastration-resistent - endokrine terapi - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - medicin for obstruktiv sygdomme, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
abiraterone mylan
mylan ireland limited - abiraterone acetat - prostatiske neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
cyclogest 400 mg vagitorier
gedeon richter plc. - progesteron - vagitorier - 400 mg
dysport 500 enheder pulver til injektionsvæske, opløsning
orifarm a/s - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder
dysport 500 enheder pulver til injektionsvæske, opløsning
2care4 aps - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder
dysport 500 enheder pulver til injektionsvæske, opløsning
abacus medicine a/s - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder
dysport 500 enheder pulver til injektionsvæske, opløsning
paranova danmark a/s - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 500 enheder